Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function
- PMID: 17928585
- DOI: 10.1152/physrev.00012.2007
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function
Abstract
It is now becoming apparent that dynamic changes occur within the interstitium that directly contribute to adverse myocardial remodeling following myocardial infarction (MI), with hypertensive heart disease and with intrinsic myocardial disease such as cardiomyopathy. Furthermore, a family of matrix proteases, the matrix metalloproteinases (MMPs) and the tissue inhibitors of MMPs (TIMPs), has been recognized to play an important role in matrix remodeling in these cardiac disease states. The purpose of this review is fivefold: 1) to examine and redefine the myocardial matrix as a critical and dynamic entity with respect to the remodeling process encountered with MI, hypertension, or cardiomyopathic disease; 2) present the remarkable progress that has been made with respect to MMP/TIMP biology and how it relates to myocardial matrix remodeling; 3) to evaluate critical translational/clinical studies that have provided a cause-effect relationship between alterations in MMP/TIMP regulation and myocardial matrix remodeling; 4) to provide a critical review and analysis of current diagnostic, prognostic, and pharmacological approaches that utilized our basic understanding of MMP/TIMPs in the context of cardiac disease; and 5) most importantly, to dispel the historical belief that the myocardial matrix is a passive structure and supplant this belief that the regulation of matrix protease pathways such as the MMPs and TIMPs will likely yield a new avenue of diagnostic and therapeutic strategies for myocardial remodeling and the progression to heart failure.
Similar articles
-
Cardiac remodeling and failure From molecules to man (Part II).Cardiovasc Pathol. 2005 Mar-Apr;14(2):49-60. doi: 10.1016/j.carpath.2005.01.005. Cardiovasc Pathol. 2005. PMID: 15780796 Review.
-
TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.J Mol Cell Cardiol. 2010 Mar;48(3):445-53. doi: 10.1016/j.yjmcc.2009.09.013. Epub 2009 Sep 30. J Mol Cell Cardiol. 2010. PMID: 19799912 Review.
-
Extracellular degradative pathways in myocardial remodeling and progression to heart failure.J Card Fail. 2002 Dec;8(6 Suppl):S332-8. doi: 10.1054/jcaf.2002.129259. J Card Fail. 2002. PMID: 12555141
-
Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.Cardiovasc Res. 2006 Feb 15;69(3):666-76. doi: 10.1016/j.cardiores.2005.10.004. Epub 2006 Jan 19. Cardiovasc Res. 2006. PMID: 16426590 Review.
-
[Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1693-6. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16854324 Chinese.
Cited by
-
Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.J Cardiovasc Transl Res. 2013 Aug;6(4):528-35. doi: 10.1007/s12265-013-9471-2. Epub 2013 May 31. J Cardiovasc Transl Res. 2013. PMID: 23722357
-
Cardiac tissue inhibitor of matrix metalloprotease 4 dictates cardiomyocyte contractility and differentiation of embryonic stem cells into cardiomyocytes: Road to therapy.Int J Cardiol. 2015 Apr 1;184:350-363. doi: 10.1016/j.ijcard.2015.01.091. Epub 2015 Feb 25. Int J Cardiol. 2015. PMID: 25745981 Free PMC article.
-
β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.Circulation. 2012 Jun 19;125(24):2993-3003. doi: 10.1161/CIRCULATIONAHA.111.066787. Epub 2012 May 18. Circulation. 2012. PMID: 22610965 Free PMC article.
-
Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction.Front Immunol. 2019 Oct 1;10:2313. doi: 10.3389/fimmu.2019.02313. eCollection 2019. Front Immunol. 2019. PMID: 31632398 Free PMC article.
-
Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure.Biomark Med. 2009 Oct 1;3(5):513-523. doi: 10.2217/bmm.09.60. Biomark Med. 2009. PMID: 20161487 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous